Literature DB >> 9335067

Molecular characteristics of mammalian dopamine receptors.

J E Lachowicz1, D R Sibley.   

Abstract

Dopamine receptors belong to a large super-gene family of receptors which are linked to their signal transduction pathways through heterotrimeric G proteins. A variety of signalling events are known to be regulated by dopamine receptors including adenylate cyclase and phospholipase activities and various ion channels. Prior to the advent of molecular cloning technology, dopamine receptors were believed to belong to two subtypes, D1 and D2. This distinction was based on both pharmacological and functional criteria. We now know that at least five different dopamine receptors exist although they can still be described as to belonging within "D1" and "D2" subfamilies. The D1 subfamily consists of two receptors-the D1 and D5, whereas the D2, D3 and D4 receptors comprise the D2 subfamily. The cloning and molecular characteristics of these five receptors are described in this review.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9335067     DOI: 10.1111/j.1600-0773.1997.tb00039.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  37 in total

Review 1.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

2.  Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats.

Authors:  Casey E O'Neill; McKenzie L LeTendre; Ryan K Bachtell
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

Review 3.  Dopamine receptors for every species: gene duplications and functional diversification in Craniates.

Authors:  Stéphane Le Crom; Marika Kapsimali; Pierre-Olivier Barôme; Philippe Vernier
Journal:  J Struct Funct Genomics       Date:  2003

4.  Inhibition of the dopamine D1 receptor signaling by PSD-95.

Authors:  Jingping Zhang; Angel Vinuela; Mark H Neely; Penelope J Hallett; Seth G N Grant; Gregory M Miller; Ole Isacson; Marc G Caron; Wei-Dong Yao
Journal:  J Biol Chem       Date:  2007-03-16       Impact factor: 5.157

Review 5.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

Review 6.  What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?

Authors:  Mayako Michino; Thijs Beuming; Prashant Donthamsetti; Amy Hauck Newman; Jonathan A Javitch; Lei Shi
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration.

Authors:  K L Conrad; K Ford; M Marinelli; M E Wolf
Journal:  Neuroscience       Date:  2010-05-07       Impact factor: 3.590

8.  Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells.

Authors:  Jiao-Jiao Xu; Si-Yuan Wang; Ye Chen; Guang-Ping Chen; Zai-Quan Li; Xue-Yan Shao; Liang Li; Wei Lu; Tian-Yan Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

Review 9.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

10.  D5 dopamine receptors are required for dopaminergic activation of phospholipase C.

Authors:  Asha Sahu; Kimberly R Tyeryar; Habiba O Vongtau; David R Sibley; Ashiwel S Undieh
Journal:  Mol Pharmacol       Date:  2008-12-01       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.